4Filing Date: Aug 31, 2026

Synopsys (SNPS)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001249802-26-000008
Total Value$14.54M
Trades4
Insiders1

Transaction Details

DE GEUS AART
EXECUTIVE CHAIR, Director·Direct
Exercise · Acquire
Common Stock
Shares+25.00K
Price$135.88
Total Value$3.40M
Shares Owned After145.42K
Transaction DateAug 28, 2026
10b5-1
DE GEUS AART
EXECUTIVE CHAIR, Director·Direct
Sell · Dispose
Common Stock
Shares-25.00K
Price$445.55
Total Value$11.14M
Shares Owned After120.42K
Transaction DateAug 28, 2026
10b5-1
Footnotes ▸

Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $440.985 to $461.850. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

DE GEUS AART
EXECUTIVE CHAIR, Director·Direct
Exercise · Dispose
Non-Qualified Stock Option (right to buy)Derivative
Shares-25.00K
Price$0.00
Total Value$0
Shares Owned After49.64K
Transaction DateAug 28, 2026
Exercise Price$135.88
ExpiresDec 12, 2026
10b5-1
Footnotes ▸

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025.

DE GEUS AART
EXECUTIVE CHAIR, Director·Indirect · by Family Trust
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After308.79K
10b5-1Holding Only

Post-Transaction Holdings

DE GEUS AART · EXECUTIVE CHAIR, Director
SecuritySharesChange
Common Stock454.21K-
Non-Qualified Stock Option (right to buy)49.64K-25.00K (-33.49%)
auto_awesome

Deep Analysis

Synopsys Executive Chair Aart de Geus exercised 25,000 options and sold the same 25,000 shares in a same-day transaction under a Rule 10b5-1 plan — a passive monetization with no net change in his direct common stock position.

lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-28 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: SYNOPSYS INC (SNPS) CIK: 0000883241 --- Reporting Owner --- Name: DE GEUS AART CIK: 0001249802 Role: Director, Officer (EXECUTIVE CHAIR) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-28 | Code: M (Exercise of derivative) Shares: +25,000 | Price: $135.88 Total Value: $3,397,000.00 Shares Owned After: 145,421 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-08-28 | Code: S (Open market sale) Shares: -25,000 | Price: $445.55 Total Value: $11,138,755.00 Shares Owned After: 120,421 | Ownership: D (Direct) Footnotes: [F1] Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $440.985 to $461.850. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. --- Derivative Transactions --- [Transaction #1] Security: Non-Qualified Stock Option (right to buy) Date: 2026-08-28 | Code: M (Exercise of derivative) Shares: -25,000 | Price: $0.00 Exercise Price: $135.88 Exercisable: N/A | Expires: 2026-12-12 Shares Owned After: 49,641 | Ownership: D (Direct) Footnotes: [F2] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) [Holding #2] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $440.985 to $461.850. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. F2: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025. --- Signature --- /s/ By: POA pursuant Mary Lai For: Aart de Geus (2026-08-31)

keid analysis is for reference only and does not constitute investment advice.